It is well-known that 1a,25-dihydroxyvitamin D 3 (1a,25(OH) 2 D 3 : 1), which is the biologically most active metabolite of vitamin D 3 , plays an important role in the body as a hormone, such as in calcium and phosphorus homeostasis, cellular differentiation, and immune responses, and inevitably, is involved in several diseases. [1][2][3][4][5][6][7][8] Therefore, its analogs could be good candidates for therapeutic agents, and so far, a large number of derivatives have been synthesized. Vitamin D analogs, such as alphacalcidol, doxercalciferol, paricalcitol, calcipotriol, tacalcitol, and maxacalcitol, are clinically used for osteoporosis, renal failure, secondary hyperparathyroidism, and psoriasis patients. 1,9) One of our previous research projects investigated previtamin D 3 analogs 10) and we became interested in modification at the 4-position of 14-epi-previtamin D 3 . Among the huge library of vitamin D 3 derivatives, few compounds possess substituents at the 4-position, and their biological effects remain unclear, except 4-fluorovitamin D analogs.11,12) We expected that 4-oxy-substitution of the previtamin D form, especially, could construct a new hydrogen bond in vitamin D receptor (VDR), and also 4-substitution would help us to understand the genomic activity of the pre-form compounds.
10)At the beginning of the study of 4-substitution in vitamin D 3 , we report the synthesis and biological evaluation of 4-hydroxy and 4-methoxy analogs of 14-epi-1a,25-dihydroxyprevitamin D 3 (14-epi-1a,25(OH) 2 preD 3 , 14-epi-pre1) and also of 1a,25(OH) 2 D 3 (1), that is, compounds 3 and 2, respectively (Fig. 1).The target compounds were divided into two fragments, A-ring and CD-ring parts, which were individually synthesized and coupled in a later step. The synthesis of the A-ring fragment is shown in Chart 1. The hydroxy group of the known compound 4 was protected as a tert-butyldimethylsilyl (TBS) ether, and transformed into a bromide using Nbromosuccinimide (NBS) and BaCO 3 .13) Then, it reacted with activated zinc powder in 1-PrOH/H 2 O to give aldehyde 5. The addition reaction of lithium (trimethylsilyl)acetylide to 5 proceeded smoothly to afford alcohol 6a, a mixture of diastereomers (major/minor 3/1). After the addition reaction, subsequent in situ reaction of the resultant lithium alkoxide with MeI afforded methoxy compound 6b as a mixture of diastereomers (major/minor 3/1). These hydroxy or methoxy groups of 6a and 6b corresponded to the 4-position in the Aring (steroid numbering), that is, we were able to construct the 4-substitution. Next, deprotection of both trimethylsilyl (TMS) and Bz groups in 6a and 6b was conducted by K 2 CO 3 in MeOH, and the following protection of the resultant hydroxyls by TBS groups gave the A-ring fragments 7a and 7b, respectively. Stereochemistry at the 4-position of 6a and 6b was determined by using Mosher esters as follows 14) : Diastereomers of compound 6a were separated by HPLC, and both reacted with (R)-and (S)-a-methoxy-a-trifluoromethylphenylacetyl chloride (MTPA chl...